Detalles de la búsqueda
1.
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study.
Cardiovasc Drugs Ther
; 37(5): 965-974, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35648242
2.
Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomized controlled trial.
Rheumatology (Oxford)
; 61(6): 2346-2359, 2022 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34605897
3.
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy.
Eur Heart J
; 40(22): 1778-1786, 2019 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30844048
4.
Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.
Diabetes Obes Metab
; 21(4): 791-800, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30393955
5.
Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project.
Stroke
; 47(6): 1605-11, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27165949
6.
Differences between rosuvastatin and atorvastatin in lipid-lowering action and effect on glucose metabolism in Japanese hypercholesterolemic patients with concurrent diabetes. Lipid-lowering with highly potent statins in hyperlipidemia with type 2 diabetes patients (LISTEN) study .
Circ J
; 78(10): 2512-5, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25186922
7.
Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
JAMA
; 312(23): 2510-20, 2014 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25401325
8.
Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study).
Diabetes Ther
; 15(6): 1403-1416, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38653904
9.
Impacts of Febuxostat on Cerebral and Cardiovascular Events in Elderly Patients with Hyperuricemia: Post Hoc Analysis of a Randomized Controlled Trial.
Clin Pharmacol Ther
; 115(6): 1358-1364, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38389505
10.
[Current status of and regional differences in CKD management and medical cooperation in Japan: from the results of a nationwide questionnaire survey for primary care physicians].
Nihon Jinzo Gakkai Shi
; 55(8): 1391-400, 2013.
Artículo
en Japonés
| MEDLINE | ID: mdl-24568036
11.
[Influence of physicians' subspecialty and training history on CKD management and medical cooperation: from the results of a nationwide questionnaire survey for primary care physicians].
Nihon Jinzo Gakkai Shi
; 55(8): 1401-11, 2013.
Artículo
en Japonés
| MEDLINE | ID: mdl-24568037
12.
Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study).
Diabetes Ther
; 14(9): 1517-1535, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37410308
13.
Febuxostat and renal outcomes: post-hoc analysis of a randomized trial.
Hypertens Res
; 46(6): 1417-1422, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36750608
14.
Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease.
Int J Cardiol
; 349: 127-133, 2022 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864084
15.
Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)-a randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events.
Am Heart J
; 159(3): 361-369.e4, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20211296
16.
Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study.
J Diabetes Investig
; 10(1): 108-117, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29660782
17.
Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia.
J Diabetes Investig
; 10(2): 383-391, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30136435
18.
Influence of blood pressure on the effects of low-dose asprin in elderly patients with multiple atherosclerotic risks.
J Hypertens
; 37(6): 1301-1307, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31022110
19.
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70).
Am J Cardiovasc Drugs
; 19(3): 299-311, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30565155
20.
Indomethacin inhibits cell growth of medullary thyroid carcinoma by reducing cell cycle progression into S phase.
Exp Biol Med (Maywood)
; 233(11): 1433-40, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18791128